Skip to search formSkip to main contentSkip to account menu

Percent Free Prostate-Specific Antigen Measurement

Known as: Free Prostate-Specific Antigen, Percent Free Prostate-Specific Antigen, free PSA 
The amount of the protein prostate-specific antigen (PSA) in the blood that is not attached to other proteins. It is compared with the amount of PSA… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection.
Highly Cited
2009
Highly Cited
2009
A [‐2]proPSA‐based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases
The aim of this study was to combine the new automated Access [‐2]proPSA (p2PSA) assay with a percent free PSA (%fPSA) based… 
Highly Cited
2009
Highly Cited
2009
Pro–Prostate-Specific Antigen Measurements in Serum and Tissue Are Associated with Treatment Necessity among Men Enrolled in Expectant Management for Prostate Cancer
Purpose: We assessed the association of quantitative clinical and pathologic information, including serum and tissue pro–prostate… 
Highly Cited
2006
Highly Cited
2006
Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations: an update.
BACKGROUND The comparability of total and free prostate-specific antigen (tPSA and fPSA) results among commercial PSA assays has… 
Highly Cited
2004
Highly Cited
2004
Surface plasmon fluorescence immunoassay of free prostate-specific antigen in human plasma at the femtomolar level.
This study describes the development of a surface plasmon fluorescence spectroscopy (SPFS)-based sandwich immunoassay, for the… 
Highly Cited
2003
Highly Cited
2003
Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial.
PURPOSE Complexed (c) prostate specific antigen (PSA) has been shown to enhance specificity for prostate cancer (CaP) detection… 
Highly Cited
2001
Highly Cited
2001
Supersensitive time-resolved immunofluorometric assay of free prostate-specific antigen with nanoparticle label technology.
BACKGROUND The extreme specific activity of the long-lifetime fluorescent europium(III) chelate nanoparticles and the enhanced… 
Highly Cited
2001
Highly Cited
2001
Identification of precursor forms of free prostate-specific antigen in serum of prostate cancer patients by immunosorption and mass spectrometry.
The structural features of the free prostate-specific antigen (F-PSA) present in human blood have not been clarified up to now… 
Highly Cited
2001
Highly Cited
2001
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ‐confined from locally‐advanced prostate cancer in total PSA‐levels below 10 ng/ml
We measured serum levels of human glandular kallikrein 2 (hK2) in patients treated with radical retropubic prostatectomy (rrP… 
Highly Cited
1996
Highly Cited
1996
In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)